Health Affairs September 26, 2023
Insulin prices have skyrocketed, but quantifying out-of-pocket insulin costs is more difficult than it seems. The landscape is complicated by various factors, including the involvement of pharmacy benefit managers (PBMs) and the complex system of rebates. These elements confound the available data concerning out-of-pocket costs for both insured and uninsured patients. Nonetheless, reports have indicated that some patients pay upwards of $1,200 monthly for insulin.
These high costs lead many with the condition to forgo or ration their insulin, the consequences of which can be lethal or cause severe long-term complications.
This experience mirrors the struggles of countless others facing different chronic illnesses and reliance on essential medications. And that is why rapidly increasing insulin costs have sparked a conversation...
Today's Sponsors
Today's Sponsor